Here are four stocks with buy rank and strong income characteristics for investors to consider today, September 14th:
Fidelity National Financial, Inc. (FNF - Free Report) : This provider of insurance products has witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.1% over the last 60 days.
Fidelity National Financial, Inc. Price and Consensus
This Zacks Rank #1 company has a dividend yield of 3.92%, compared with the industry average of 1.28%. Its five-year average dividend yield is 2.91%.
Fidelity National Financial, Inc. Dividend Yield (TTM)
Annaly Capital Management, Inc. (NLY - Free Report) : This diversified capital manager has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.4% over the last 60 days.
Annaly Capital Management Inc Price and Consensus
This Zacks Rank #2 (Buy) company has a dividend yield of 16.15%, compared with the industry average of 5.32%. Its five-year average dividend yield is 12.2%.
Annaly Capital Management Inc Dividend Yield (TTM)
Arbor Realty Trust, Inc. (ABR - Free Report) : This company that invests in multifamily, single-family rental, and commercial real estate markets, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.3% over the last 60 days.
Arbor Realty Trust Price and Consensus
This Zacks Rank #2 company has a dividend yield of 10.87%, compared with the industry average of 3.79%. Its five-year average dividend yield is 9.38%.
Arbor Realty Trust Dividend Yield (TTM)
Morgan Stanley (MS - Free Report) : This financial holding company, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 21.7% over the last 60 days.
Morgan Stanley Price and Consensus
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 2.78%, compared with the industry average of 0.28%. Its five-year average dividend yield is 2.39%.
Morgan Stanley Dividend Yield (TTM)
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong income characteristics for investors to consider today, September 14th:
Fidelity National Financial, Inc. (FNF - Free Report) : This provider of insurance products has witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.1% over the last 60 days.
Fidelity National Financial, Inc. Price and Consensus
This Zacks Rank #1 company has a dividend yield of 3.92%, compared with the industry average of 1.28%. Its five-year average dividend yield is 2.91%.
Fidelity National Financial, Inc. Dividend Yield (TTM)
Annaly Capital Management, Inc. (NLY - Free Report) : This diversified capital manager has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.4% over the last 60 days.
Annaly Capital Management Inc Price and Consensus
This Zacks Rank #2 (Buy) company has a dividend yield of 16.15%, compared with the industry average of 5.32%. Its five-year average dividend yield is 12.2%.
Annaly Capital Management Inc Dividend Yield (TTM)
Arbor Realty Trust, Inc. (ABR - Free Report) : This company that invests in multifamily, single-family rental, and commercial real estate markets, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.3% over the last 60 days.
Arbor Realty Trust Price and Consensus
This Zacks Rank #2 company has a dividend yield of 10.87%, compared with the industry average of 3.79%. Its five-year average dividend yield is 9.38%.
Arbor Realty Trust Dividend Yield (TTM)
Morgan Stanley (MS - Free Report) : This financial holding company, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 21.7% over the last 60 days.
Morgan Stanley Price and Consensus
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 2.78%, compared with the industry average of 0.28%. Its five-year average dividend yield is 2.39%.
Morgan Stanley Dividend Yield (TTM)
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MS - FREE
Get the latest research report on FNF - FREE
Get the latest research report on ABR - FREE
Get the latest research report on NLY - FREE